RxDoctor Payments Data

Redonda Marshall, APRN

Family · Columbia, MONPI 1275599615

Payments from drug & device makers

$254in general payments, 2019–2025

Across 9 payments — averaging $28.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$54
  • Novo Nordisk$41
  • GSK$29
  • Boston Scientific$26
  • Boehringer Ingelheim$25
  • Dexcom, Inc.$21
  • plus $58 from 3 others

What the payments were for

  • Food & beverage$254100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$254 in reported general payments places this provider in the 40th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$73,322
Medicare patients
294
Services billed
801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin57$47,248
EliquisApixaban54$44,302
OzempicSemaglutide21$26,567
FarxigaDapagliflozin Propanediol23$18,826
JanuviaSitagliptin Phosphate11$10,819
Atorvastatin Calcium498$4,054
Levothyroxine Sodium373$3,743
Losartan Potassium360$3,255
ArexvyRsvpref3 Antigen/As01e/Pf11$3,144
Semglee (Yfgn)Insulin Glargine-Yfgn11$2,855
Omeprazole204$2,528
SynthroidLevothyroxine Sodium39$2,175
Gabapentin126$1,979
Dexlansoprazole DrDexlansoprazole12$1,900
Amlodipine Besylate394$1,817

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$25$47,24857 claims
Novo NordiskOzempic$41$26,56721 claims
MerckJanuvia$20$10,81911 claims
GSKArexvy$29$3,14411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,812 family providers in Missouri.

Other family in Columbia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →